Study · Journal of market access & health policy · Sep 14
Real-World Shelf Life of Epinephrine Auto-Injectors in Canada: Implications for Renewal Frequency and Patient Burden (opens in a new tab)
Papastergiou J, Vang Lybech M, Mertz C, et al.
Although patients in Canada at risk of anaphylaxis are recommended to maintain access to two in-date epinephrine auto-injectors (EAIs) at all times, underuse during emergencies remains common.